131 related articles for article (PubMed ID: 9042156)
1. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas.
Bugert P; Gaul C; Weber K; Herbers J; Akhtar M; Ljungberg B; Kovacs G
Lab Invest; 1997 Feb; 76(2):203-8. PubMed ID: 9042156
[TBL] [Abstract][Full Text] [Related]
2. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
Bugert P; Kovacs G
Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
4. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.
Speicher MR; Schoell B; du Manoir S; Schröck E; Ried T; Cremer T; Störkel S; Kovacs A; Kovacs G
Am J Pathol; 1994 Aug; 145(2):356-64. PubMed ID: 7519827
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
[TBL] [Abstract][Full Text] [Related]
6. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors.
Palmedo G; Fischer J; Kovacs G
Lab Invest; 1997 Dec; 77(6):633-8. PubMed ID: 9426401
[TBL] [Abstract][Full Text] [Related]
10. Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites.
Steiner G; Sidransky D
Am J Pathol; 1996 Dec; 149(6):1791-5. PubMed ID: 8952515
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
[TBL] [Abstract][Full Text] [Related]
12. Assessing genetic heterogeneity of renal cell tumors.
Mirghomizadeh F; Kupka S; Blin N
Anticancer Res; 1999; 19(2C):1467-70. PubMed ID: 10365125
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
Kovacs A; Storkel S; Thoenes W; Kovacs G
J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.
Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ
Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042
[TBL] [Abstract][Full Text] [Related]
15. Distal nephron renal tumors: microsatellite allelotype.
Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
[TBL] [Abstract][Full Text] [Related]
16. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
[TBL] [Abstract][Full Text] [Related]
18. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
